Wilcox A. J., Weinberg C. R., Baird D. D. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N. Engl. J. Med., 1995; 333:1517–1521.
Wilkens J., Critchley H. Progesterone receptor modulators in gynaecological practice. J. Fam. Plann. Reprod. Health Care, 2010; 36 (2):87–92.
Wilkins L., et al. Masculinization of the female fetus associated with administration of oral and intramuscular progestins during gestation: non-adrenal female pseudohermaphrodism. J. Clin. Endocrinol. Metab., 1958; 18:559–585.
Wilkins L. Masculinization of the female fetus due to the use of certain synthetic oral progestins during pregnancy. Arch. Anat. Microsc. Morphol. Exp., 1959; 48 (Suppl):313–329.
Williams N. I., et al. Effects of follicular phase exercise on luteinizing hormone pulse characteristics in sedentary eumenorrhoeic women. Clin. Endocrinol. (Oxf.), 1994; 41:787–794.
Williams S. C., Donahue J., Muasher S. J. Vaginal progesterone therapy during programmed cycles for frozen embryo transfer: an analysis of serum progesterone levels and pregnancy rates [abstract P-363]. Fertil. Steril., 2000; 74 (Suppl 1):S209.
Wilson K. M., et al. A prospective study of dietary acrylamide intake and the risk of breast, endometrial, and ovarian cancers. Cancer Epidemiol. Biomarkers Prev., 2010 October; 19 (10):2503–2515.
Wilson C. W., Loh H. S. Vitamin C and fertility. Lancet, 1973; 2:859–860.
Wilson M. A. GABA physiology: modulation by benzodiazepines and hormones. Crit. Rev. Neurobiol., 1996; 10:1–17.
Wingo C. S., Greenlee M. M. Progesterone: not just a sex hormone anymore? Kidney International 2011; 80:231–233.
Wise D. D., Felker A., Stahl S. M. Tailoring treatment of depression for women across the reproductive lifecycle: the importance of pregnancy, vasomotor symptoms, and other estrogen-related events in psychopharmacology. CNS Spectr, 2008; 13:647–662.
Wise P. M., et al. Estrogens: trophic and protective factors in the adult brain. Front Neuroendocrinol., 2001; 22:33–66.
Women’s Health. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 2002l; 288:321–333.
Woods K. S., Reyna R., Azziz R. Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome. Fertil. Steril., 2002; 77:1125–1127.
Woods M. N., et al. Hormone levels during dietary changes in premenopausal African-American women. J. Natl. Cancer Inst., 1996; 88:1369–1374.
World Health Organization. WHO Laboratory manual for the examination of human semen and semen-cervical mucus interaction. New York: Cambridge University Press, 1993.
Wu J. M., Zelinski M. B., Ingram D. K., Ottinger M. A. Models ovarian aging and menopause: current theories, hypotheses, and research. Experimental Biology and Medicine, 2005; 230:818–828.
Wu J. T., Dickmann, Johnson D. C. Effects of ovariectomy or hypophysectomy on day one of pregnancy on development and transport of fertilized rat eggs. J. Endocr., 1971; 49:507–513.
Wu Y., et al. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics, 2006; 1:106–111.
Wyatt K. M., et al. The effectiveness of GnRHa with and without ’add-back’ therapy in treating premenstrual syndrome: a meta analysis. BJOG, 2004; 111:585–593.
Xia J., Reigada D., Mitchell C. H., Ren D. CatSper channel-mediated Ca2+ entry into mouse sperm triggers a tail-to-head propagation. Biol. Reprod., 2007; 77:551–559.
Xiao E., Ferin M. Stress-related disturbances of the menstrual cycle. Ann. Med., 1997; 29:215–219.
Yang S., Thiel K. W., Leslie K. K. Progesterone: the ultimate endometrial tumor suppressor. Trends Endocrinol. Metab., 2011b; 22 (4):145–152.
Ying C., et al. Progesterone receptor gene expression in preimplantation pig embryos. Eur. J. Endocrinol., 2000; 143:697–703.
Yip S. K., et al. Accuracy of clinical diagnostic methods of threatened abortion. Gynecol. Obstet. Invest., 2003; 56:38–42.
Yonkers K. A., Pearlstein T., Rosenheck R. A. Premenstrual disorders: bridging research and clinical reality. Arch. Womens Ment. Health, 2003; 6 (4):287–292.
Yoshida T. Infertility update: use of assisted reproductive technology. J. Am. Pharm. Assoc., 1999; 39:65–72.
Younis J. S., et al. A simple multivariate score could predict ovarian reserve, as well as pregnancy rate, in infertile women. Fertil. Steril., 2010; 94 (2):655–661.
Yovel I., et al. High progesterone levels adversely affect embryo quality and pregnancy rates in in vitro fertilization and oocyte donation programs. Fertil. Steril., 1995; 64:128–131.
Yui J., et al. Cytotoxicity of tumor necrosis factor-alpha and gammainterferon against primary human placental trophoblast. Placenta, 1994; 15:819–835.
Zachariades E., et al. Changes in placental progesterone receptors in term and preterm labour. Placenta, 2012; 33:367–372.